These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 10587139)

  • 1. Pediatric body applications of FDG PET.
    O'Hara SM; Donnelly LF; Coleman RE
    AJR Am J Roentgenol; 1999 Apr; 172(4):1019-24. PubMed ID: 10587139
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of therapy response by FDG PET in pediatric patients.
    Franzius C; Schober O
    Q J Nucl Med; 2003 Mar; 47(1):41-5. PubMed ID: 12714953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Added value of positron emission tomography with fluoro-18-deoxyglucose as the tracer (FDG-PET) in clinical problem cases in oncology].
    Soepenberg O
    Ned Tijdschr Geneeskd; 2000 Oct; 144(41):1979-80. PubMed ID: 11048563
    [No Abstract]   [Full Text] [Related]  

  • 4. Guest editorial: the conception of FDG-PET imaging.
    Alavi A; Reivich M
    Semin Nucl Med; 2002 Jan; 32(1):2-5. PubMed ID: 11839067
    [No Abstract]   [Full Text] [Related]  

  • 5. Procedure guideline for tumor imaging using fluorine-18-FDG. Society of Nuclear Medicine.
    Schelbert HR; Hoh CK; Royal HD; Brown M; Dahlbom MN; Dehdashti F; Wahl RL
    J Nucl Med; 1998 Jul; 39(7):1302-5. PubMed ID: 9669415
    [No Abstract]   [Full Text] [Related]  

  • 6. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Technical bases and regulatory principles].
    Bourguet P;
    Bull Cancer; 2003 Feb; 90 Spec No():S18-22. PubMed ID: 12739333
    [No Abstract]   [Full Text] [Related]  

  • 7. [Present status of PET images: clinical FDG PET in oncology].
    Inoue T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1999 Nov; 59(13):737-44. PubMed ID: 10614103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Computerized tomography and F-18-FDG positron emission tomography in staging of malignant lymphomas: a comparison].
    Bumann D; de Wit M; Beyer W; Beese M; Lübeck M; Bücheler E; Clausen M
    Rofo; 1998 May; 168(5):457-65. PubMed ID: 9617362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined FDG and [F-18]fluoride whole-body PET: a feasible two-in-one approach to cancer imaging?
    Hoegerle S; Juengling F; Otte A; Altehoefer C; Moser EA; Nitzsche EU
    Radiology; 1998 Oct; 209(1):253-8. PubMed ID: 9769840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [2002 Standards, Options and Recommendations for the use of [18F]-FDG (PET-FDG) in cancerology].
    Bourguet P;
    Bull Cancer; 2003 Feb; 90 Spec No():S1-109. PubMed ID: 12744225
    [No Abstract]   [Full Text] [Related]  

  • 12. [Guidelines for tumor diagnosis with (F-18)-fluorodeoxyglucose (FDG)].
    Knapp WH
    Nuklearmedizin; 1999; 38(6A):267-9. PubMed ID: 10510829
    [No Abstract]   [Full Text] [Related]  

  • 13. [Positron emission tomography (PET) and (F-18)-fluorodeoxyglucose in (FDG) in cancerology].
    Maublant J; Vuillez JP; Talbot JN; Lumbroso J; Muratet JP; Herry JY; Artus JC
    Bull Cancer; 1998 Nov; 85(11):935-50. PubMed ID: 9951421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoplasms in a pediatric population: 2-[F-18]-fluoro-2-deoxy-D-glucose PET studies.
    Shulkin BL; Mitchell DS; Ungar DR; Prakash D; Dole MG; Castle VP; Hernandez RJ; Koeppe RA; Hutchinson RJ
    Radiology; 1995 Feb; 194(2):495-500. PubMed ID: 7824731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET applications in pediatrics.
    Shulkin BL
    Q J Nucl Med; 1997 Dec; 41(4):281-91. PubMed ID: 9542419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A tabulated summary of the FDG PET literature.
    Gambhir SS; Czernin J; Schwimmer J; Silverman DH; Coleman RE; Phelps ME
    J Nucl Med; 2001 May; 42(5 Suppl):1S-93S. PubMed ID: 11483694
    [No Abstract]   [Full Text] [Related]  

  • 17. [Scintigraphy with FDG-PET].
    Carril Carril JM
    Rev Esp Med Nucl; 2000 Aug; 19(4):315. PubMed ID: 11203265
    [No Abstract]   [Full Text] [Related]  

  • 18. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
    Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
    Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-fluorodeoxyglucose uptake of bone and soft tissue sarcomas in pediatric patients.
    Walter F; Federman N; Apichairuk W; Nelson S; Phelps ME; Allen-Auerbach M; Walter MA; Czernin J
    Pediatr Hematol Oncol; 2011 Oct; 28(7):579-87. PubMed ID: 21936620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Indications of PET imaging].
    Lomeña Caballero FJ; Simó Perdigó M
    Med Clin (Barc); 2003 May; 120(19):742-9. PubMed ID: 12781085
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.